Why is Symbiox Investme falling/rising?

As of 24-Jul, Symbiox Investment & Trading Co Ltd's stock price is currently at 2.76, reflecting an increase of 0.13 or 4.94%. Today's price summary indicates that the stock has outperformed its sector by 5.68% and has experienced a trend reversal, gaining after two consecutive days of decline. Despite this recent uptick, the stock has shown a negative return of -7.69% over the past month and a significant -49.08% year-to-date. The company has an attractive valuation with a low Price to Book Value of 0.3, and while it has generated a return of -4.50% over the past year, its profits have remained stable with a PEG ratio of 0.1. However, the company is facing challenges with operating losses and weak long-term fundamental strength, which may hinder its recovery.
In the broader market context, the stock's short-term performance has been slightly better than the benchmark, with a 1-week return of 0.00% compared to the Sensex's -0.09%. Despite this, the stock has consistently underperformed against the benchmark over the last three years, which raises concerns about its long-term viability. The liquidity of the stock appears adequate, with a delivery volume increase of 1.99% against the 5-day average, suggesting some investor interest. However, the overall negative sentiment stemming from the company's operating losses and poor long-term growth prospects may overshadow the recent positive price movement.